Pamela Ling, MD, MPH

Internist

Dr. Pamela Ling is an internist and primary care doctor with a special interest in caring for underserved urban populations.

Ling's current research investigates the intersection of tobacco use, media and social marketing with an emphasis on young people. Her work focuses on understanding how tobacco marketing encourages youth and young adults to begin using tobacco, and how to counter-engineer the same strategies to improve tobacco control programs.

Ling earned her medical degree from UCSF, followed by a Master of Public Health degree from the University of California, Berkeley. She completed a residency in medicine at UCSF and a fellowship at the UCSF Center for AIDS Prevention Studies.

Ling is a member of the American Public Health Association and the Society for General Internal Medicine. She is a professor of medicine at UCSF.

Clinics

General Internal Medicine
1545 Divisadero St., First and Second Floors
San Francisco, CA 94115
New Patient Appointments:
(844) 727-8273 (PCP-UCSF)
Office: (415) 353–7900
Fax, First Floor: (415) 353–2583
Fax, Second Floor: (415) 353–2640

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

Board Certification

Internal Medicine, American Board of Internal Medicine

Academic Title

Professor

More about Pamela Ling

Education

UCSF Medical School 1996
University of California, Berkeley , Master of Public Health 2000

Residencies

UCSF , Medicine 1999

Fellowships

UCSF Center for AIDS Prevention Studies 2002

Selected Research and Publications

  1. Benowitz-Fredericks C, McQuoid J, Sheon N, Olson S, Ling PM. Voluntary Smoke-Free Measures Among Oklahoma Nightlife Owners: Barriers and Facilitators. Health Promot Pract. 2018 Mar 01; 1524839918764897.
  2. McQuoid J, Thrul J, Ling P. A geographically explicit ecological momentary assessment (GEMA) mixed method for understanding substance use. Soc Sci Med. 2018 Apr; 202:89-98.
  3. Robertson L, Hoek J, Blank ML, Richards R, Ling P, Popova L. Dual use of electronic nicotine delivery systems (ENDS) and smoked tobacco: a qualitative analysis. Tob Control. 2018 Feb 01.
  4. Elias J, Ling PM. Origins of tobacco harm reduction in the UK: the 'Product Modification Programme' (1972-1991). Tob Control. 2018 Jan 12.
  5. Hendlin YH, Veffer JR, Lewis MJ, Ling PM. Beyond the brotherhood: Skoal Bandits' role in the evolution of marketing moist smokeless tobacco pouches. Tob Induc Dis. 2017; 15:46.
  6. Ling PM, Holmes LM, Jordan JW, Lisha NE, Bibbins-Domingo K. Bars, Nightclubs, and Cancer Prevention: New Approaches to Reduce Young Adult Cigarette Smoking. Am J Prev Med. 2017 Sep; 53(3S1):S78-S85.
  7. Hiatt RA, Handley MA, Ling PM, Burchard E, Thakur N, Bibbins-Domingo K. Origins of Cancer Disparities in Young Adults: Logic Models to Guide Research. Am J Prev Med. 2017 Sep; 53(3S1):S95-S102.
  8. Schillinger D, Ling PM, Fine S, Boyer CB, Rogers E, Vargas RA, Bibbins-Domingo K, Chou WS. Reducing Cancer and Cancer Disparities: Lessons From a Youth-Generated Diabetes Prevention Campaign. Am J Prev Med. 2017 Sep; 53(3S1):S103-S113.
  9. Hendlin YH, Elias J, Ling PM. The Pharmaceuticalization of the Tobacco Industry. Ann Intern Med. 2017 08 15; 167(4):278-280.
  10. Llamas J, Holmes LM, Lisha NE, Ling PM. Psychometric evaluation of an abbreviated version of the intragroup marginalization inventory. J Ethn Subst Abuse. 2017 Jul 14; 1-20.
  11. Fallin-Bennett A, Lisha NE, Ling PM. Other Tobacco Product Use Among Sexual Minority Young Adult Bar Patrons. Am J Prev Med. 2017 Sep; 53(3):327-334.
  12. Elias J, Hendlin Y, Chaffee BW, Ling PM. Don't throw smokeless tobacco users under the bus. Addict Behav. 2018 Feb; 77:289-290.
  13. Hoek J, Thrul J, Ling P. Qualitative analysis of young adult ENDS users' expectations and experiences. BMJ Open. 2017 03 07; 7(3):e014990.
  14. Popova L, So J, Sangalang A, Neilands TB, Ling PM. Do Emotions Spark Interest in Alternative Tobacco Products? Health Educ Behav. 2017 Aug; 44(4):598-612.
  15. Kostygina G, England L, Ling PM. Kostygina et al. Respond. Am J Public Health. 2016 12; 106(12):e2-e3.
  16. Kostygina G, Ling PM. Tobacco industry use of flavourings to promote smokeless tobacco products. Tob Control. 2016 11; 25(Suppl 2):ii40-ii49.
  17. Gorukanti A, Delucchi K, Ling P, Fisher-Travis R, Halpern-Felsher B. Adolescents' attitudes towards e-cigarette ingredients, safety, addictive properties, social norms, and regulation. Prev Med. 2017 Jan; 94:65-71.
  18. Burbank AD, Thrul J, Ling PM. A Pilot Study of Retail 'Vape Shops' in the San Francisco Bay Area. Tob Prev Cessat. 2016; 2(Suppl).
  19. Lisha NE, Jordan JW, Ling PM. Peer crowd affiliation as a segmentation tool for young adult tobacco use. Tob Control. 2016 10; 25(Suppl 1):i83-i89.
  20. Thrul J, Lisha NE, Ling PM. Tobacco Marketing Receptivity and Other Tobacco Product Use Among Young Adult Bar Patrons. J Adolesc Health. 2016 Dec; 59(6):642-647.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.